1 / 38

Se, come e quando l’ottimizzazione è necessaria? How and When Optimization Is Needed?

Se, come e quando l’ottimizzazione è necessaria? How and When Optimization Is Needed?. M. Cristina Porciani Firenze. There is no doubt that CRT has revolutionized treatment for patients with medically resistant LV systolic dysfunction, and a broad QRS

ruthr
Download Presentation

Se, come e quando l’ottimizzazione è necessaria? How and When Optimization Is Needed?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Se, come e quando l’ottimizzazione è necessaria? How and When Optimization Is Needed? M. Cristina Porciani Firenze

  2. There is no doubt that CRT has revolutionized treatment for patients with medically resistant LV systolic dysfunction, and abroad QRS • However up to 40% ma not benefit fromdeviceimplantation or even deteriorate • The exactreasonforlackofresponseisstillunclear , butmay due tofactorssuchas minimal preimplantdyssynchrony, inadeguate leadplacement,scarburden, and alsodevicesettingwithinappropiatepacingparametersfor a givenindividual

  3. CurrentCRT devices allow manipulation of the AV and VV timings CRT OPTIMIZATION • However, multiple single centre and few multicenter trials have provided controversial data • Whileseveral invasive and non invasive studieshavedemonstratedthatoptimizing AV and VV intervals can acutelyimprovehemodynamicparameters, evidenceabout the croniceffectisscars • In addition, multiple methodologies have been proposed to optimize AV and VV intervals but no consensus has been reached on which methodology should preferably be used.

  4. Gras D. PACE 2009

  5. CRT OPTIMIZATION AV optimization VV optimization

  6. PhysiologicalPrinciples AV Optimization AV optimization

  7. Appropriate AVD

  8. PhysiologicalPrinciples AV Optimization

  9. PhysiologicalPrinciples AV Optimization

  10. Evidencefor acute improvementinducedby AV optimization in traditionalpacemakers 15pts with severe HF Nishimuraet al .JACC 1995

  11. Evidencefor acute improvementinducedby AV optimization in CRT Average percentage change in systolic parameters as a function of 5 normalized AV delays for each pacing chamber (RV,LV, and BV). Tested AV delays were normalized to the patient’s PR interval minus 30 ms Auricchio A. Circulation 1999

  12. Evidencefor acute improvementinduced AV optimization : Echocardiographicmethods

  13. Evidencefor acute improvementinduced AV optimization in CRT Relative improvement in the Doppler parameters vs. baseline value after AV optimization Open bars standard settings Hatched bars optimized CRT Solid bars relative variability of the parameters during optimization Stockburger M. et al Europace 2006

  14. Whataboutcronicimprovementinduced AV optimization ? Echocardiographyoptimizationofatrioventricular delay was included in several randomized trials in CRT MIRACLE Ritter’s method CARE-HF : iterative method COMPANION: a device-based algorithm

  15. Evidenceforlong-termimprovementinducedby AV optimization ECO-Opt AV AV 120ms (n 20 pts) (n 20 pts) *P .05 vs baseline Sawhney NS, HeartRhythm 2004

  16. SMART-AV Trial prospectivelyrandomizedptsto a fixed AV(120ms), echooptimized AV and opimized with Smart Delay ( electrogrambasedalgorithm ) in a 1:1:1ratio Pts mean follow-up 5.8±monts Ellenbogen K A Circulation 2010

  17. SMART-AV Trial Ellenbogen K A Circulation 2010

  18. SMART-AV Trial Ellenbogen K A Circulation 2010

  19. Evidenceforlong-termimprovementinducedby AV optimization RetrospectiveStudy 205 pts Mean Follow-up 35 months Kaplan–Meier estimates showing time to the primary endpoint, survival free of cardiac hospitalization Adlbrecht C Eur J Clin Invest 2010

  20. Adlbrecht C Eur J Clin Invest 2010

  21. 75 Pts non respondersto CRT Mullens W JACC 2009

  22. 75 Pts non respondersto CRT Mullens W JACC 2009

  23. PhysiologicalPrinciples VV Optimization VV optimization

  24. ►Despitesimilar QRS morphologyptswith HF and LBBB maypresentdifferentpattensofventricularasynchrony ►The presenceofscar and slow or blockedconduction areasaffects the timetoachieve a global depolarizationof the ventricle

  25. Effectof RV, LV and BiVPacing on depolarisationwavefons RV LV BiV Lambiaseet al. Heart 2004

  26. 9 pz 11pz GSCA: Global SystolicContractionAmplitude Sogaard P et al .Circ 2002

  27. LVEF% GSCA mm LVEDV ml LVESV ml BaselineSimultaneousSequentialBaselineSimultaneousSequential Sogaard P et al .Circ 2002

  28. Echocardiographicmethodsfor V-V optimization

  29. Optimizationguidedbyechocardiography Lim SH Europace 2008

  30. Optimizationguidedby invasive monitoring Lim SH Europace 2008

  31. Long-term benefit of CRT optimization when compared with simultaneous biventricular pacing 121 pts, randomized simultaneous (30) optimized ( 91) Boriani G et al Am H J 2005

  32. Leon AR JACC 2005

  33. 100 pts 49 non opt 51 opt ◄ Vidal B et al Am J Cardiol 2007

  34. 100 pts 49 non opt 51 opt ◄ Vidal B et al Am J Cardiol 2007

  35. DECREASE_HF trial three-armrandomized LV pace only, simultaneous and optimized sequential biventricular pacing (1:1:1 ratio). 306 pts Rao RK Circulation 2007

  36. CRT OPTIMIZATION AV optimization VV optimization Resultsabout the long term benefit inducedby V-V optimizationappeardiscouragingmainlyfor VV interval

  37. Conclusions • Optimization can improvehemodynamicsacutely, but long-term clinical improvements are currently less convincing • Until more definitive evidence is available, however, we must do the best for our patients • It is important to remember that HF pts even a small increase in exercise capacity can make a vast personal difference • Optimization has never been shown to be detrimental so it should certainly be performed in those not receiving benefit with empiric settings, but should also be considered in all other patients

More Related